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ABSTRACT 
Aims  
Thoracic Ascending Aortic Aneurysms (TAA) are characterized by elastic fibre 
breakdown and cystic medial degeneration within the aortic media, associated with 
progressive SMC rarefaction. The TGF-β/Smad2 signaling pathway is involved in this 
process. Since pericellular fibrinolytic system activation is able to degrade adhesive 
proteins, activate MMPs, induce SMC disappearance and increase the bio-availability of 
TGF-β, we explored the plasminergic system in TAA. 
Methods and Results 
Ascending aortas (21 controls and 19 TAAs (of 3 different aetiologies)) were analyzed. 
Immunohistochemistry showed accumulation of t-PA, u-PA & plasmin in TAAs, 
associated with remaining SMCs. Over-expression of t-PA, and u-PA was confirmed by 
RT-PCR, immunoblotting and zymography on TAA extracts and culture medium 
conditioned by TAA. Plasminogen was present on the SMC surface and inside 
cytoplasmic vesicles, but plasminogen mRNA was undetectable in TAA medial layer. 
Plasmin-antiplasmin complexes were detected in TAA-conditioned medium and 
activation of the fibrinolytic system was associated with an increased fibronectin 
turnover. Fibronectin-related material was detected immunohistochamically in dense 
clumps around SMCs and co-localized with Latent TGF-β Binding Protein-1. 
Conclusions 
These observations indicate that the fibrinolytic pathway could play a critical role in 
TAA progression, via direct or indirect impact on ECM and consecutive modulation of 
TGF-β bio-availability. 
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INTRODUCTION 
Proteolytic degradation of the extracellular matrix, including adhesive glycoproteins 
and microfibrils1, 2, of the medial layer, leading to elastin fibre network breakdown, is 
necessary for aneurysm formation in large arteries and is therefore a common 
pathophysiological pathway regardless of aneurysmal aetiology and localization3. In 
thoracic ascending aneurysm (TAA), this proteolytic injury is promoted by smooth 
muscle cell (SMC) rarefaction 4 and the subsequent development of areas of cystic 
medial degeneration 5, 6, 7. Studies of mediators of extracellular matrix breakdown in 
human TAA8, 9 of various aetiologies10-12 have mainly focused on matrix 
metalloproteinases13, but the serine proteases, including fibrinolytic proteases, have 
received less attention. Plasmin generation could participate in MMP activation and 
smooth muscle cell (SMC) detachment via degradation of adhesive proteins including 
fibronectin14; and is also claimed to be a major player regulating TGF-β1 bio-availability 
(see15 for review). 
Recent data obtained in Marfan syndrome have focused interest on TGF-β1 bio-
availability/Smad2 signalling in vascular SMCs, as a molecular link between the initial 
FBN1 gene mutation and secondary dilatation of the aorta16. We recently showed that 
Latent TGF-β Binding Protein-1 (LTBP-1) and Smad2 are overexpressed at both 
transcript and protein levels in human TAA. In contrast, mRNA coding for TGF-β1 is not 
increased although there is an increased in the storage of its latent form 17. These 
observations were made in human TAA of diverse etiologies: (i) Marfan syndrome 
related to FBN1 gene mutations, but also mutations of TGFBR2, (ii) associated with 
bicuspid aortic valve (BAV), and (iii) degenerative forms. Contrasting with 
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atherothrombotic aneurysms of the abdominal aorta18, TAA are devoid of any 
intraluminal thrombus19 and present no major leukocyte infiltrate20. 
In order to further characterize the potential involvement of plasmin activation in 
the development of TAA, we explored on samples of the aortic wall the tissue expression 
and release of t-PA, u-PA and plasmin, as well as fibronectin degradation fragments as 
end-products. We showed that t-PA and u-PA are overexpressed in TAA tissue samples 
leading to plasminogen activation. Furthermore fibronectin is overexpressed but also 
overdegraded, and co-localizes with Latent TGF-β Binding Protein-1. 
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MATERIALS AND METHODS 
Aneurysmal aortic wall taken during surgery from 19 patients with aortic 
aneurysm of the ascending aorta of various aetiologies (Marfan, TAA associated with 
biscuspid aortic valve (BAV) and degenerative form) were collected over a 2 year period 
(Table 1)19 in Xavier Bichat hospital (Paris, France) and in the Heart Institute (INCOR) 
of Sao Paulo, Brazil. Since the outer curvature of the ascending aorta (usual site of 
maximal dilatation) and the inner curvature (usually less or not dilated) could differ by 
several morphological aspects and biological mediators, only the outer curvature was 
used for histological and biochemical studies in the present study. Acute dissections of 
the ascending aorta were excluded from the present study because thrombus formation in 
the false channel involves plasminogen and plasminogen activator retention and 
activation,.This study was approved by the Ethical Committee (Ambroise Paré Hospital 
(Boulogne, France) 04/14/2005) and by the Heart Institute of Sao Paulo, Brazil. All 
patients signed informed consent. Samples of normal walls of the ascending aorta and 
aortic arch were obtained in 21 subjects at the time of organ collection for heart/lung 
transplantation after authorization from the French Biomedicine Agency. Unfortunately, 
anonymity was required during this process and so no clinical data is available for the 
controls. Measurements of plasma concentrations of plasmin-antiplasmin complexes 
were performed on citrated plasma. Plasma was obtained from normal volunteers (Centre 
d’Investigation Preventive et Clinique”, IPC, Paris, France), 21 and, prior to surgery, from 
patients with a thoracic aortic aneurysm. These 2 populations were matched for age and 
sex (Table 1). 
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Histology 
Samples of ascending aortic wall, taken from the outer curvature (n=19 for 
TAA, n=21 for controls) were fixed in 3.7% paraformaldehyde for 24 hours and then 
processed for routine paraffin embedding. Aortic convexity wall samples were oriented to 
obtain cross-sections, perpendicular to the axis of blood flow in vivo. Five micrometer 
thick serial sections were stained with haematoxylin/eosin, nuclear red/Alcian blue 
(proteoglycans), Sirius red (collagen fibres)/haematoxylin or orcein (elastic fibres). Serial 
sections of these tissues were also used for immunohistochemical staining. Standard 
histology was performed to evaluate features characteristic of TAA disease: disruption of 
the elastic and collagen fibre network, smooth muscle cell rarefaction and presence of 
cystic medial degeneration areas. 
Immunohistochemistry  
Serial sections (n=10 per group) were deparaffinized, rehydrated and antigen 
retrieval was performed in citrate buffer, at pH 7 for plasminogen, tissue- and urokinase-
type plasminogen activators (t-PA, u-PA). Endogenous peroxidase was blocked with 3% 
H2O2 in aqueous solution for 5 minutes, and non-specific binding was blocked with 
normal horse serum for 30 minutes (except for plasminogen detection). We used 
polyclonal antibodies for α-actin (Dako, 10µg/ml), fibronectin (Sigma, 5µg/ml), human 
smooth muscle myosin heavy chains, SM2 (Abcam, 10µg/ml), and t-PA (Abcam, 
5µg/ml) and monoclonal antibodies for plasmin/plasminogen (Technoclone, 40µg/ml) 
and u-PA (Calbiochem, 10µg/ml). All sections were incubated overnight with the 
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primary antibody in TBS/TC solution (Tris-buffered saline – 0.2% Tween – 0.6% casein, 
pH6), followed by the secondary antibody (Kit LSAB-DAKO) for 30 minutes. The 
binding reaction was detected using DAB. Slides were then counterstained with Mayer’s 
hematoxylin. Negative control immunohistochemical procedures consisted of substitution 
of the primary antibody by equivalent amounts of naive mouse and/or rabbit IgG. This 
procedure gave consistently negative results. Sections of pathological aortic tissue were 
compared to normal aortas.  
Since Latent TGF-β Binding Protein-1 (LTBP-1) antibodies could not be used 
on fixed tissue, cryostat sections (5 µm) were used for studying fluorescent localization 
of fibronectin, LTBP-1 and TGF-β1 . Briefly, cryostat sections were post-fixed in 
acetone, washed, blocked and incubated with the specific anti-fibronectin polyclonal 
antibody (Sigma, 5µg/ml) for one hour at room temperature and revealed by anti-rabbit 
Alexa-488 (green, 4µg/ml). A similar procedure was performed for LTBP-1 (R&D 
system,5 µg/ml) and TGF-β1 (Santa Cruz, 5 µg/ml) by using specific monoclonal 
antibodies for each and an anti-mouse Alexa-555 (red, 4µg/ml) for revelation. The 
spontaneous autofluorescence of elastin was revealed by ultraviolet transillumination. 
 
Immunoeclectron microscopy for fibrinolytic serine-proteases 
For immunoelectron microscopy (n=5 per goup), small pieces of tissue were 
fixed in 3% glutaraldehyde in 0.15M phosphate buffer at pH 7.2 for 1 hour, followed by 
postfixation in 1% osmium tetroxide in 0.9% sodium chloride for 1 hour. Fixed material 
was stained en bloc in 0.5% aqueous uranyl acetate overnight. After this procedure, the 
samples were dehydrated in a graded acetone series, and embedded in Araldite resin. 
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Ultrathin sections, at 70nm thick, were obtained using an LKB ultramicrotome, equipped 
with a diamond knife and placed on formvar-coated, 200-mesh, nickel grids. Sections 
were treated with 0.5M Sodium Periodate in aqueous solution for 15 minutes to remove 
the resin and to reduce any free aldehyde groups present. 
The sections were incubated overnight with the primary antibody at a dilution of 
40µg/ml for plasmin/plasminogen in TBS/TC solution (Tris-buffered saline – 0.2% 
Tween – 0.6% casein, pH6). After rinsing in TBS/TC solution (8 times; 1min), the 
sections were incubated in a solution containing the gold-conjugate (bridging antibody 
RαG/M. DAKO]) for 2hr. After a new rinsing with TBS/TC solution (4 times; 1min) and 
distilled water (8 times; 5min), sections were double-stained with uranyl acetate and lead 
citrate. The grids were studied and photomicrographed in a Philips TECHNAI 12 
transmission electron microscope, operating at 80kV. 
 
Biochemistry 
Preparation of tissue culture media 
Since the adventitia of samples from surgery is always contaminated by 
coagulated blood, adventitial removal was gently performed, and the aortic media was 
washed 3 times before use. Aortic media samples from 19 TAA and 21 control aortas 
were washed 3 times in PBS solution, cut into small pieces, weighed and incubated in 
RPMI buffer (6mL buffer per g of sample), for 18 h at 37°C as previously described19. 
The sample of culture medium, containing the proteins released by the aortic tissue were 
then collected, centrifuged and frozen. 
Tissue extraction 
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Protein extraction was performed directly from frozen aortic medial tissue at -80 °C. The 
aortic medial samples were first cryogenically pulverized in liquid nitrogen, using a 
freezer mill (model 6750 SPEX SamplePrep). About 100 to 300 mg of crushed powder 
per sample were subsequently used. The powder was homogenised using a potter in 5 
times weight-to-volume of extraction buffer (5M urea, 2M thiourea, 2% CHAPS, 2% 
SB3-10, 20mM Tris pH 7 and 1% of protease inhibitor cocktail) at 4°C with sporadic 
vortexing. Homogenates were centrifuged at 6000 g for 10 min. Supernatants were 
transferred to new tubes and centrifuge at 14000 g for 2 min. All centrifugation steps 
were carried out at 4°C. The final supernatant was divided into 50µL aliquots and stored 
at -20°C until analysis. Total proteins were quantified by the method of Bradford. 
Immunoblotting 
Equal amounts of protein (25 µg) were loaded onto 4-12% bis-tris acrylamide gels 
(Criterion Gels, BioRad) under reducing conditions, as well as 2.5 ng of recombinant 
human tPA (r-TPA from actilyse, Boehringer Ingelheim and from HYPEN BioMed) and 
2.5 ng of the complex between tPA and the plasminogen activator inhibitor type 1 (PAI-
1) as positive control. The complex was formed by mixing equal amounts of both 
compounds at neutral pH and incubating at room temperature for 30 min. Gels were 
subjected to electrophoresis. Protein transfer to nitrocellulose membrane was performed 
at 300 mA for 1h. Membranes were blocked for 1h in TBS-T solution containing 5% 
(w/v) non-fat dry milk. Several anti t-PA antibodies were tested on tissue extracts and all 
give several bands. Among these, sheep-derived polyclonal antibody against human tPA 
(Abcam) was chosen as the most specific. Incubation in 2 µg/mL of primary antibody in 
1% of blocking buffer was performed overnight at 4°C in a sealed plastic bag under 
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agitation. Secondary anti-sheep IgG antibodies conjugated with horseradish peroxidase 
(Jackson Immuno Research Laboratories) at 1µg/mL were incubated for 1h at room 
temperature. Antigen visualisation was achieved by a 20 min X-ray film exposure using 
luminescent ECL (GE Healthcare) substrate. Negative quality control of primary 
antibody specificity was done by loading in duplicate one sample from the TAA group in 
which the primary antibody incubation was omitted. Finally, to control for equal loading 
of protein on SDS-PAGE gels the membrane was reblotted against β-actin (Sigma). For 
each sample, t-PA was normalized to the quantity of β-actin and values were reported as 
a percentage. Quantification of bands was performed with Image J software 
(http://rsbweb.nih.gov/ij/). The non-specific band was excluded. 
Immunoblotting of uPA and fibronectin was carried out similarly to that of tPA, but gel 
loading was done at constant volume (3 µL for fibronectin and 20 µL for uPA) of tissue-
culture medium for each sample. Primary antibodies were monoclonal against: human 
uPA-B chain (American Diagnostica, 1 µg/mL)a and  against fibronectin (Sigma). 
Casein zymography 
Samples of tissue culture medium, containing the proteins released by the aortic 
tissue during incubation, were analyzed by electrophoresis on 10% SDS-polyacrylamide 
gels containing 1mg/ml of α-casein for detection of u-PA (Sigma)22. Molecular mass 
determinations were made with reference to pre-stained protein standards (BioRad) co-
electrophoresed in the gels. Serine–proteases were inhibited by aprotinin and u-PA 
selectively by 2 µM amiloride. 
ELISA 
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Plasmin-antiplasmin (PAP) complexes were detected in samples of tissue-
conditionned culture medium and plasma using a commercially available kit (American 
Diagnostica) according to the manufacturer’s instructions. 
Real-Time PCR 
Powder of crushed aortic tissue was incubated in lysis buffer (OMEGA - vWR) and the 
solution then filtered. Total RNA from aneurysmal and control tissue was extracted, 
using the EZNA kit (OMEGA - vWR), according to the manufacturer’s instructions. 
0.2µg of RNA was reverse-transcribed using Taq Polymerase (Invitrogen). Real-time 
PCR was performed in the LightCycler system with SYBR Green detection (Roche 
Applied Science) using 5ng of cDNA. mRNA levels were normalized to GAPDH 
mRNA17. The primers used are presented in Table 2. 
 
Statistical analysis 
Results are expressed as box plots, in which the median is shown. Upper and 
lower limits of boxes represent interquartiles (25th and 75th), whereas upper and lower 
bars show percentiles (10th and 90th). Statistical analysis was performed with Statview 
software using the nonparametric Mann-Whitney test. Differences between measured 
variables were considered significant for p≤0.05. 
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RESULTS 
 
Patient characteristics 
In this study, we included 19 patients with TAA [7 patients with Marfan syndrome (7 
males), 6 patients with TAA associated with a bicuspid aortic valve (BAV, 5 males, 1 
female) and 6 older patients with the degenerative form (5 males, 1 female)]. These 3 
aetiologies differ by the age of surgical aortic root replacement (Table 1). One Marfan 
and one BAV patient had aortic valve insufficiency and one BAV patient had calcified 
stenosis; no aortic valve disease was associated with the degenerative form of TAA. At 
surgery the mean aortic root diameter was slightly smaller in Marfan patients than in 
patients with TAA of the other aetiologies (Table 1). No cases of syphilitic aneurysm or 
dissection were included in this series. 
 
Histological characterization 
Aortic sections from controls (n=21) showed a normal arrangement of the media in 
which the layers of SMCs were separated by prominent elastic lamellae. These lamellae 
were interconnected by a network of small elastic and collagen fibres and proteoglycans4. 
Aortic sections from all aneurysmal aortas (n=19) showed disorganization and 
important breakdown of the elastic and collagen network (Fig 1 A, B and C, Fig 2 A,B 
and C), associated with cell rarefaction corresponding to more or less diffuse areas (cystic 
medial degeneration) of vacuolated basophilic material (Fig. 1 C). The accumulation of 
this amorphous, Alcian blue-positive material often involved several elastic lamellar 
units12. Some morphological differences were observed between the different etiologies: 
Marfan patients showed more pronounced and diffuse cystic medial degeneration despite 
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their young age (Table 1), corresponding to more diffuse elastic fibre breakdown, 
whereas cystic media degeneration and corresponding elastic fibre breakdowns was 
usually less diffuse and more localized in TAA associated with BAV (Fig 2A & B).  
Age related degenerative forms were characterized by diffuse degradation of the medial 
extracellular matrix usually associated with intimal proliferation (data not shown) as 
previously reported23. Occasionally fatty streaks were present, but did not differ 
morphologically from those in control aorta, and did not predominated in the outer 
curvature.  
Viable medial cells stained positively for SM α-actin (not shown) and SM myosin 
(Fig. 1D) in both controls and TAA, indicating that they were smooth muscle cells 
(SMCs). In addition, some isolated retracted SMCs were present within the cystic medial 
degeneration areas in aneurysmal aortic wall (Fig. 1C & D). No inflammatory cells were 
present (data not shown). 
Electron microscopy revealed of SMCs of a contractile phenotype in the normal 
aortic wall (Fig 1E, F) whereas SMCs from the aneurysmal aorta exhibited a more 
synthetic phenotype with a well developed rough endoplasmic reticulum and Golgi 
apparatus (Fig 1G, H). 
 
Plasminogen activators 
t-PA was mainly associated with the surviving SMCs present in aneurysmal aortic 
wall whereas it was only present in small amounts in association with normal SMCs in 
normal aortic wall (Fig. 3A & B). Immunoblot revealed a clear increase in free tPA from 
aneurysmal aortic wall compared to normal aorta (Fig. 3C). A band corresponding to free 
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tPA (64 KDa), which is the only form that has fibrinolytic activity, indicated an almost 
three-fold increase in the protein concentration (Fig. 3D). A faint band corresponding to 
the antiprotease-tPA complex was also observed (100 kDa, Fig. 3C). The negative 
control revealed the presence of a non-specific band around 50kDa that, consequently, 
was not used for the tPA analysis. These data, obtained at the protein level, were 
confirmed at the transcript level by quantitative RT-PCR showing a significant (p<0.001) 
increase in t-PA mRNA expression in aneurysmal as compared to normal aortic wall 
(Fig. 3E).  
u-PA was also associated with the surviving SMCs in aneurysmal aortic wall (Fig. 
4 A, B & C). u-PA activity was visualized by casein zymography24 in tissue-conditioned 
medium. A 33.5 kDa protein was observed in conditioned medium (Fig. 4D) which 
predominated in aneurysmal tissue as compared to controls (p<0.01, Fig. 4E). This LMW 
serine protease activity was inhibited by amiloride (2 µM), an inhibitor of u-PA25(data 
not shown). A similar band could be generated by incubating urine, a source of two-chain 
u-PA, with active MMP-726, or plasmin (data not shown) and was identified as LMW 
urokinase by immunoblot (Fig. 4E). Similarly to t-PA, u-PA mRNA was significantly 
increased in TAA tissue compared to controls (p= 0.005, Fig. 4F). 
 
Plasminogen uptake and plasmin generation 
In normal aortic tissue, immunoreactivity for plasmin/plasminogen was detected on 
the luminal side and presented a negative gradient across the media to the more external 
layers (Fig. 5A). In the medial layer of TAA, plasmin/plasminogen immunostaining was 
associated with the remaining SMCs, but also with extracellular material (Fig. 5B & 
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inset). In contrast, plasminogen/plasmin were not retained in areas of cystic medial 
degeneration. Extracellular matrix components were positive for plasmin/plasminogen 
when analyzed by electron microscopy, in both normal and aneurismal aorta although the 
staining was more intense in the latter. Plasminogen/plasmin labeling was associated with 
the cell surface and was also present inside the cytoplasmic vesicles near to the cell 
membrane in SMCs from aneurysmal aorta (Fig. 4C). 
Immunoblots using an anti-plasminogen antibody directed towards the kringle 1-3 
region allowing detection of both plasminogen and plasmin, confirmed the 
immunohistological data. In normal aorta, only very faint bands were observed at the 
expected position for plasminogen and plasmin (Fig. 4D), whereas in aneurysmal aorta, 
both plasminogen and plasmin could be detected, and the intensity of the bands was 
considerably higher (O.D. 84 +/- 10 in TAA versus 21 +/- 3.5 in controls, p<0.01). 
Plasminogen mRNA was not detected in normal or aneurysmal aortic wall in usual 
conditions (PCR > 50 cycles). 
Plasmin-Antiplasmin (PAP) complex concentration was higher in samples of 
tissue-conditioned medium obtained from aneurysmal aorta than in those from normal 
aorta (p<0.05, Fig. 5D). Interestingly, the concentration of PAP complexes was also 
significantly higher in plasma from patients with TAA (n=37, 1459 +/- 39 ng/ml) than in 
plasma from age- and gender-paired normal volunteers (n=30, 956+/- 30 ng/ml) (p<0.05). 
 
Fibronectin as a pericellular target for plasmin 
Immunostaining of cellular fibronectin was homogeneous in normal aortic tissue 
throughout the extracellular space between the elastic lamellae (Fig. 6A & B). In contrast, 
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fibronectin distribution was heterogeneous in aneurysmal aortic wall. Areas of acellular 
cystic medial degeneration were devoid of fibronectin (Fig. 6C), whereas some clumps of 
compact fibronectin immunostaining were observed around the remaining retracted 
SMCs (Fig. 6C & D). This abnormal distribution was associated with a significant global 
increase in fibronectin mRNA levels in TAA tissue compared to controls (p<0.001, Fig. 
6E). 
Fibronectin degradation products were detected by immunoblot in cuture medium 
conditioned by both normal and aneurysmal aortas. Quantification of fibronectin bands 
showed that degradation products were significantly increased in TAA-conditioned 
medium compared to controls (p<0.01) (Fig. 6F).  
It has already been shown that Latent TGF-β Binding Protein-1 (LTBP-1) is 
associated with fibronectin in cell cultures27. Since plasmin is capable of cleaving 
fibronectin, and as a consequence, of mobilizing latent TGF-β1/LTBP-1 complexes28, 29, 
we explored the localization of LTBP-1, TGF-β1 and fibronectin in TAA by 
immunoflurorescence (Figs. 2 and Fig. 7). In controls, fibronectin, LTBP-1 and TGF-β1 
were regularly distributed and co-localized around SMCs (Fig. 7A). In contrast, the 
distribution of fibronectin, LTBP-1 and TGF-β1 was more heterogeneous in TAA but 
these 3 proteins remained co-localized, exhibiting the distribution described above for 
fibronectin ( Fig. 7B). 
Comparison of TAA of Marfan origin to that associated with BAV (Fig 2) 
showed that despite the differences observed in the morphology of cystic media 
degeneration, there was no difference in the co-localization of compacted fibronectin and 
LTBP-1 in the edge of the cystic degeneration areas (Fig 2 E/F, H/I, K/L). 
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DISCUSSION 
Our morphological data confirmed, in TAA having reached the stage requiring 
surgery, that cystic medial degeneration co-localizes with extracellular matrix 
breakdown, including elastic fibre disruption, and vacuolated areas of mucoid material 
retention12, 20 and smooth muscle cell rarefaction 10, 30-32. 
In the normal aortic wall, smooth muscle cells have a contractile phenotype 
recognized by electron microscopy33. In the aneurysmal wall, SMCs are quite different, 
with a significant enrichment in rough endoplasmic reticulum, Golgi apparatus and 
vesicles, suggesting a switch to a more secretory and phagocytic phenotype34. The 
presence of cytoplasmic vesicles in close proximity to the cell membrane, suggests 
endocytic activity, which is in agreement with the well established capacity of SMCs to 
acquire accessory endocytic/phagocytic activities in pathological conditions35, 36. 
We explored the fibrinolytic pathway in the aneurysmal aortic wall because 
plasmin, produced by t-PA or u-PA, is able to activate MMPs and TGF-β1, and to cause, 
either directly or indirectly pericellular fibronectin degradation and SMC rarefaction15,14. 
Both t-PA and u-PA were associated with the remaining SMCs in aneurysmal aortic wall 
as previously described in aortic dissection37. This suggests that plasminogen activation 
could occur in the pericellular space14. In addition, increased expression of both t-PA and 
u-PA at the transcription as well as at the protein level were observed, and LMW-uPA 
was found to be active in the TAA samples. LMW-uPA can be generated from sc-uPA by 
plasmin and also by MMP-726, that we have recently reported to be localized in areas of 
cystic medial degeneration7. Therefore, more conditions favoring pericellular activation 
of plasminogen appear to be present in aneurysmal aorta than in normal aorta. 
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Nevertheless, the stimuli responsible for plasminogen activator overexpression by smooth 
muscle cells remain to be elucidated. 
In normal aortic wall, plasmin/plasminogen immunoreactivity presented a clear, 
consistent, negative gradient across the media from the luminal side outwards and was 
predominantly associated with SMCs. This is compatible with a convection process from 
the plasma to the outer aortic wall38 which is probably increased in TAA due to 
perturbation of endothelial permeability19, 39 and elastic lamellar degradation40. 
Plasminogen is a plasma protein, synthesized by the liver and circulating in the 
micromolar range; and we could not detect plasminogen mRNA in the aortic media. In 
pathological areas, the plasminogen/plasmin immunoreactivity was intense, always 
associated with the remaining SMCs, whereas the cystic medial degeneraion areas were 
strictly negative. In addition, biochemical analysis indicated that TAA samples contained 
increased amounts of plasminogen/plasmin compared to control aorta. Plasminogen and 
t-PA could bind to external cell surface via annexin II41 leading to pericellular plasmin 
activation and fibronectin degradation14. Annexin II overexpression has been already 
reported in human42 and experimental43 abdominal aneurysm. Furthermore, the increased 
plasmin/antiplasmin complexes provide evidence of plasminogen activation by t-PA or u-
PA synthesized by smooth muscle cells within the pathological aortic samples.  
The localization of plasminogen/plasmin in close association with SMC membranes 
and their presence within cytoplasmic vesicles was demonstrated by electron microscopy. 
Indeed, the pericellular localization of plasmin/plasminogen could be related to its 
binding to free lysine residues on membrane proteins14. Cell membrane-bound 
plasminogen can be cleared from the extracellular space by endocytosis44. The presence 
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of plasminogen/plasmin within vesicles indicates that, in TAA, SMCs can endocytose 
plasmin-antiprotease complexes45. 
Analysis of fibronectin is in keeping with the possible involvement of plasmin 
activation. Fibronectin is the main adhesive protein involved in SMC spreading and 
adhesion46. Its expression is under the control of the TGF-β1 and Smad2 signaling 
pathway47, 48 which is recognized to be involved in TAA development 49. The in vivo 
relevance of this point was further suggested by the increased fibronectin mRNA in TAA 
compared to controls. These data confirm earlier studies showing an increased expression 
of fibronectin in the outer curvature of TAA associated with BAV as compared to the 
aneurysmal inner curvature50, 51. The compacted fibronectin observed in the pericellular 
space of the remaining, retracted SMCs provides evidence for important modifications of 
the SMC micro-environment in TAA. The increased quantity of degraded fibronectin and 
solubilized products observed in TAA conditioned-medium compared to control, also 
provides evidence of proteolytic degradation. Plasmin is a proteolytic enzyme 14, capable 
of degrading and solubilizing fibronectin in the pericellular space. The proteolytic 
degradation of fibronectin could be one of the links between pericellular matrix protein 
degradation and SMC apoptosis46. In parallel, the microfibrillar structure of fibrillin, 
responsible for elastic fibre assembly52, is strictly dependent on the integrity of 
fibronectin53, 54. Therefore, pericellular plasmin activation could also indirectly impact 
elastic fibre structure in TAA. 
The degradation of fibronectin in TAA could have another important consequence 
by increasing LTBP-1/TGF-β1 release. Since LTBP-1 sequesters TGF-β1 in the 
extracellular matrix and is bound to pericellular fibronectin with a high affinity27 via an 
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integrin-dependent process55,56, we explored the localization of fibronectin, LTBP-1 and 
TGF-β1 in human aortic wall. We demonstrated here, for the first time, a co-localization 
of LTBP-1 with fibronectin in the pericellular space of SMCs in the normal human aortic 
wall. In diseased aortic wall, the association persists between compacted fibronectin, 
LTBP-1, and TGFβ-1, suggesting that plasmin-dependent fibronectin degradation could 
release LTBP-1/latent TGF-β1 complexes28, 29. These findings are in agreement with our 
previous study17, showing an increased storage of latent TGF-β1 by the aneurysmal wall 
as compared to normal aorta, without a parallel increase in TGF-β1 mRNA expression.  
In conclusion, the present observational study suggests, for the first time, that 
plasmin and plasminogen activators accumulate in the vicinity of the remaining SMCs in 
the medial layer of TAA. In parallel, fibronectin is both overexpressed, abnormally 
accumulating around suffering SMCs in close association with LTBP-1, and 
overdegraded, indicating an increased turnover. 
Our results indicate that the fibrinolytic pathway is activated in TAA, and may 
participate in proteolysis of the extracellular matrix, resulting in disorganization of the 
aortic wall and the subsequent increase in LTBP-1/latent TGF-β1 release. 
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FIGURE LEGENDS  
Figure 1. Morphology of the ECM and SMCs: Sections of medial layer of human 
aortic aneurysmal wall stained with orcein (A), picrosirius red (B), alcian blue (C) or 
immunolabeled for human smooth muscle myosin heavy chains SM2 (D). E to H; 
electron micrographs of longitudinal ultrathin sections showing smooth muscle cells from 
normal aorta (E and G) and from aneurysmal aorta (F and H). 
A- Disrupted elastic lamellae are visible in aneurysmal wall; the negative stain indicating 
the absence of elastic lamellae and fibres corresponds to the area of cystic medial 
degeneration (star). B- Collagen fibres, stained in red, are also absent or disrupted within 
the areas of cystic medial degeneration (star). C– A large area of typical cystic medial 
degeneration (blue), observed in human aortic aneurysmal media. D – Immunostaining 
for human smooth muscle myosin (SMCs) heavy chains, SM2, indicating the presence of 
smooth muscle cells in the aortic media. Retracted cells predominate in the vicinity of 
areas of mucoïd degeneration. Orientation: intima top and adventitia bottom in A & B 
and intima right and adventitia left in C &D 
E – Typical SMC of a contractile phenotype, showing myofilaments (actin and myosin) 
present in the sarcoplasm (Sc) and the presence of a surrounding basement membrane 
(arrows). The extracellular matrix (ECM) shows an arrangement of collagen fibrils; 
nucleus (N). F – Higher magnification of (E) showing the SMC sarcoplasm (Sc) in 
details, with the presence of myofilaments (Sc) typical of the contractile phenotype. The 
arrows show the basement membrane. G – The cytoplasm of a SMC in the TAA group 
exhibits a typical synthetic phenotype with the presence of well developed rough 
endoplasmic reticulum (RER) and few myofilaments (MF) restricted to the cell 
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periphery. Extracellular matrix (ECM); nucleus (N). H - Higher magnification showing 
details of the cytoplasm. Note the presence of ribosomes (arrows) adhering to the outside 
of the membrane of the endoplasmic reticulum (RER). Myofilaments (MF); nucleus (N). 
Figure 2: Immunohistological characterization of TAA from Marfan and BAV 
patients: A – Normal aorta showing preserved elastic lamellae (blue spontaneous 
fluorescence). B – Marfan patients showing diffuse degradation of elastic lamellae. C – 
BAV patients showing focaldegradation of elastic fibres . D, E & F – Fibronectin 
immunostaining showing compacted fibronectin around zones of cystic medial 
degeneration, in both TAA aetiologies (Marfan and BAV, E, F) as compared to normal 
aorta (D).– G, H & I- similar clumpsof LTBP in Marfan and BAV (E, F) as compared to 
normal aortas (G) J, K & L – Merge of fibronectin and LTBP-1 showing their 
colocalization in Marfan and BAV aortas. 
Figure 3. Tissue-Plasminogen activator (t-PA): A - Normal aorta showing a regular 
distribution of small amounts of t-PA, associated with SMCs throughout the media. B – 
In the TAA group, t-PA immunostaining was more intense and also associated with the 
remaining SMCs (arrows) whereas the mucoid areas (star) were always negative.  
C – t-PA western blot from protein extracts of aorta medial layer. Line: NS: negative 
control, controls & TAA samples, rt-PA and PAI-1/tPA complex (2.5 ng). * Band of 
PAI-1/tPA complex 100 kDa; ** Band of tPA 64 kDa; NS- non-specific band, bottom β-
actin loading control band.  
D-  Densitometric quantification showing the overexpression of t-PA in TAA.  
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E – Real Time PCR of t-PA mRNA, showing a significant increase in t-PA mRNA 
expression in TAA taken together compared to control (Control: 0.34±0.75; TAA: 
0.93±0.88; p<0.0001). 
Figure 4.  Urokinase (u-PA): A - normal aorta: the distribution of u-PA 
immunostaining was less homogeneous than that of t-PA. B & C - Aneurysmal aortic 
wall: u-PA staining is intense and clearly associated with SMCs (arrows in Fig. 3C). 
Orientation: intima right and adventitia left in all cases.  
D – Zymography detected a 33.5 KDa band which was more intense in TAA-conditioned 
medium than control. This band was amiloride-sensitive and could be generated by co-
incubation of urine (containing urokinase) and active MMP-7. This band was also 
observed by western blot in MMP-7 treated urine. 
E- Densitometric quantification of the caseinolytic LMW band showing the over activity 
of u-PA in TAA. 
F – Real Time PCR of u-PA mRNA showing a significant increase in u-PA mRNA 
expression in TAA groups taken together compared to controls (Control: 0.25±0.32; 
TAA: 0.91±1.1; p<0.005). 
 
Figure 5. Cellular localization of plasminogen/plasmin: Histological sections of 
normal (A) and aneurysmal (B) aorta immunostained for plasminogen/plasmin. In both 
samples, positive immunostaining for plasminogen is present in the intima and is 
associated with SMCs in the media. A negative gradient is present from the lumen to the 
more external parts of the aortic wall. No immunostaining is present in the mucoid areas 
(stars). Inset: Plasminogen is localized both inside and outside the SMCs surrounding the 
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mucoid area (arrow). Orientation: intima top and adventitia bottom in both cases. C – 
Ultrathin section of human aorta of the TAA group treated with an antibody against 
plasminogen/plasmin labeled with small gold particles and viewed under the transmission 
electron microscope. Note the positivity for this protease inside the endocytic vesicles 
(Cv; double arrows), at the cell surface (arrows) and labeling the extracellular molecules 
(small arrows), ECM: extracellular matrix. Bar represents 0.5µm.  
D- Plasminogen/Plasmin immunoblotting on tissue extracts: Extracts from control and 
TAA aortic samples were analyzed using an antibody that recognizes both plasminogen 
and plasmin, in non-reducing conditions. The intensity of the bands was significantly 
greater in TAA samples, as indicated by densitometric quantification. Plasmin/anti-
plasmin was measured in tissue-culture media by ELISA. 
 
Figure 6. Fibronectin overexpression, clumping and degradation: Immunostaining of 
fibronectin (hematoxylin counterstaining, blue).  Normal aorta: a regular distribution of 
fibronectin between the elastic lamellae is observed (A), in the extracellular space 
surrrounding the SMCs (B). In aneurysmal aorta, immunostaining of fibronectin was 
heterogeneous: areas of cystic medial degeneration were devoid of fibronectin (star) (C), 
whereas clumps of fibronectin appeared around retracted SMCs in the vicinity of mucoid 
areas (D). 
E- Real Time PCR of fibronectin mRNA showing a significant increase in fibronectin 
mRNA expression in TAA groups taken together compared to controls (Control: 
0.16±0.21; TAA: 0.9±0.8; p<0.0001). 
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F - Fibronectin western blot of samples of aortic tissue-conditioned medium. Line: 1: 
negative control, 2 to 6: control group, 7 to 11: TAA group, 12: molecular weight marker 
(kDa), 13: Aortic SMC supernatant incubated without plasmin, 14: Aortic SMC 
supernatant incubated with plasmin. 
Figure 7: Colocalisation of LTBP-1, TGF-β1 and fibronectin: Elastin in blue 
(ultraviolet), fibronectin in green and Latent TGF-β Binding Protein-1 and TGF-β1 in 
red; overlay of the two fluorophores in yellow. 
A: Normal aorta shows intact elastin, and the regular distribution of pericellular 
fibronectin, LTBP-1 and TGF-β1;  
B: Aneurysmal aorta shows degraded elastin and clumps of fibronectin colocalizing with 
LTBP-1 and TGF-β1 accumulation (X20).  
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Table 1: Patient characteristics
Table 2: list of q-PCR primers used for mRNA quantification in tissue
Plasminogen forward 5’-GCCCCATAGACACAGCATTT-3’
reverse 5’-CCTACAACCCTTCCAGGACA-3’
t-PA forward 5’-CCAGATCGAGACTCAAAGCC-3’
reverse 5’-GACCCATTCCCAAAGTAGCA-3’
u-PA forward 5’-ACTACTACGGCTCTGAAGTCACCA-3’
reverse 5’-GAAGTGTGAGACTCTCGTGTAGAC-3’
Fibronectin forward 5’-AGATAAATCAACAGTGGGAGC-3’
reverse 5’-CCAGATCATGGAGTCTTTAGG-3’
GAPDH forward 5’-GGGCAYCCTGGGCTAMACTGA-3’
reverse 5’-TGCTCTTGCTGGGGCTGGT-3’
71 ± 6.6
57.8±8.6
52 ± 4.8
54±6.8
36 ± 8.4
51.2±3.6
52.8 ± 7.4
54.8±7.8
47.3 ± 4.6
33.7±4.4
Mean age ± SD
Aortic Diameter
(mm)
5571718Males
6671921Total number
DegenerativeBAVMonogenicTAAcontrols
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